The U.S. Is Quietly Giving A Chinese Billionaire A Monopoly On A New Liver Cancer Drug (POLITICS)
It’s the at least second time this year the federal government has proposed giving exclusive rights for taxpayer-funded research to a foreign pharmaceutical giant.